Mawer Investment Management Ltd. grew its stake in Novanta Inc. (NASDAQ:NOVT – Free Report) by 16.9% during the fourth quarter, HoldingsChannel reports. The fund owned 457,160 shares of the technology company’s stock after acquiring an additional 66,012 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Novanta were worth $54,397,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Danske Bank A S purchased a new position in Novanta during the 3rd quarter worth $40,000. Allworth Financial LP grew its stake in Novanta by 978.4% during the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after buying an additional 362 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in Novanta by 120.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after buying an additional 233 shares during the last quarter. ANTIPODES PARTNERS Ltd purchased a new position in Novanta during the 4th quarter worth $53,000. Finally, Farther Finance Advisors LLC grew its stake in Novanta by 1,291.4% during the 4th quarter. Farther Finance Advisors LLC now owns 487 shares of the technology company’s stock worth $58,000 after buying an additional 452 shares during the last quarter. 98.35% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
NOVT has been the topic of several research analyst reports. Robert W. Baird boosted their target price on Novanta from $144.00 to $173.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. Finally, Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $173.00.
Novanta Stock Up 2.6%
Novanta stock opened at $163.46 on Tuesday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56. The business’s 50-day simple moving average is $134.91 and its two-hundred day simple moving average is $129.20. The company has a market cap of $5.82 billion, a PE ratio of 118.45 and a beta of 1.62. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $165.56.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.03. The business had revenue of $257.71 million for the quarter, compared to the consensus estimate of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Equities analysts anticipate that Novanta Inc. will post 3.59 EPS for the current year.
Insider Activity
In other Novanta news, CFO Robert Buckley sold 9,957 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the sale, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the sale, the chief executive officer owned 42,761 shares in the company, valued at approximately $6,432,537.23. The trade was a 14.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 23,957 shares of company stock worth $3,136,229. Company insiders own 1.20% of the company’s stock.
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Further Reading
- Five stocks we like better than Novanta
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
